PMC:7556165 / 47706-47923 JSONTXT

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T239","span":{"begin":87,"end":97},"obj":"Species"},{"id":"T240","span":{"begin":87,"end":91},"obj":"Species"},{"id":"T241","span":{"begin":135,"end":145},"obj":"Species"},{"id":"T242","span":{"begin":135,"end":139},"obj":"Species"},{"id":"T243","span":{"begin":169,"end":177},"obj":"Species"},{"id":"T244","span":{"begin":169,"end":173},"obj":"Species"}],"attributes":[{"id":"A239","pred":"ncbi_taxonomy_id","subj":"T239","obj":"NCBItxid:2697049"},{"id":"A240","pred":"ncbi_taxonomy_id","subj":"T240","obj":"NCBItxid:694009"},{"id":"A241","pred":"ncbi_taxonomy_id","subj":"T241","obj":"NCBItxid:2697049"},{"id":"A242","pred":"ncbi_taxonomy_id","subj":"T242","obj":"NCBItxid:694009"},{"id":"A243","pred":"ncbi_taxonomy_id","subj":"T243","obj":"NCBItxid:694009"},{"id":"A244","pred":"ncbi_taxonomy_id","subj":"T244","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T294","span":{"begin":0,"end":217},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1304","span":{"begin":110,"end":114},"obj":"Gene"},{"id":"1314","span":{"begin":87,"end":97},"obj":"Species"},{"id":"1315","span":{"begin":135,"end":145},"obj":"Species"},{"id":"1316","span":{"begin":169,"end":177},"obj":"Species"}],"attributes":[{"id":"A1304","pred":"pubann:denotes","subj":"1304","obj":"Gene:59272"},{"id":"A1314","pred":"pubann:denotes","subj":"1314","obj":"Tax:2697049"},{"id":"A1315","pred":"pubann:denotes","subj":"1315","obj":"Tax:2697049"},{"id":"A1316","pred":"pubann:denotes","subj":"1316","obj":"Tax:694009"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T5182","span":{"begin":110,"end":114},"obj":"Protein"}],"attributes":[{"id":"A5182","pred":"uniprot_id","subj":"T5182","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T190","span":{"begin":128,"end":133},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T383","span":{"begin":128,"end":133},"obj":"Body_part"}],"attributes":[{"id":"A383","pred":"fma_id","subj":"T383","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T219","span":{"begin":87,"end":97},"obj":"Disease"},{"id":"T220","span":{"begin":87,"end":91},"obj":"Disease"},{"id":"T221","span":{"begin":135,"end":145},"obj":"Disease"},{"id":"T222","span":{"begin":135,"end":139},"obj":"Disease"},{"id":"T223","span":{"begin":169,"end":177},"obj":"Disease"},{"id":"T224","span":{"begin":169,"end":173},"obj":"Disease"}],"attributes":[{"id":"A219","pred":"mondo_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A220","pred":"mondo_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A221","pred":"mondo_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A222","pred":"mondo_id","subj":"T222","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A223","pred":"mondo_id","subj":"T223","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A224","pred":"mondo_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1304","span":{"begin":110,"end":114},"obj":"Gene"},{"id":"1314","span":{"begin":87,"end":97},"obj":"Species"},{"id":"1315","span":{"begin":135,"end":145},"obj":"Species"},{"id":"1316","span":{"begin":169,"end":177},"obj":"Species"}],"attributes":[{"id":"A1304","pred":"tao:has_database_id","subj":"1304","obj":"Gene:59272"},{"id":"A1314","pred":"tao:has_database_id","subj":"1314","obj":"Tax:2697049"},{"id":"A1315","pred":"tao:has_database_id","subj":"1315","obj":"Tax:2697049"},{"id":"A1316","pred":"tao:has_database_id","subj":"1316","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T294","span":{"begin":0,"end":217},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The affinity difference in vitro was confirmed also in vivo by the stronger binding of SARS-CoV-2 S331–524 to ACE2 expressed on cells (SARS-CoV-2: EC50 = 0.08 μg/ml vs. SARS-CoV: EC50 = 0.96 μg/ml) (Tai et al., 2020)."}